Skip to main content
Premium Trial:

Request an Annual Quote

BD Completes Accuri Cytometers Buy

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced the completion of its acquisition of Accuri Cytometers for an undisclosed amount.

Based in Ann Arbor, Mich., Accuri develops personal flow cytometers. The acquisition, announced last month during BD's first quarter earnings release, helps expand the use of flow cytometry technology in regions where ease of use and affordability are critical, BD said.

"The acquisition … complements and broadens BD's offerings for life scientists by making flow cytometry more accessible to a wider audience of scientists and clinicians," William Rhodes, president of BD Biosciences, said in a statement.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.